User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Apr 25 2015 18:36 IST RSS 2.0
 
1 to 20 of 2,560    
Indian biotech firm Stempeutics Research gets China Patent for its novel stem cell drug 25.4.2015 ET: Biotech
Stempeutics' stem cell-based drugs enable living tissues to repair or replace tissue or organ function lost due to age, disease, damage or congenital defects.
Also found in: [+]
Fears over EU plan for strict drug patent regime 14.4.2015 TOI: Home
As Prime Minister Narendra Modi and German Chancellor Markel are set to discuss the India-EU free trade agreement, public health groups and Indian pharmaceutical companies are concerned that the European Commission may push for stringent patent regime for cheaper medicines manufactured at home.
Also found in: [+]
What India Inc can learn from IBM 10.4.2015 ET: Corporate Dossier
IBM's global research head Arvind Krishna on its patents factory, innovation engine and working with Nobel laureates.
Also found in: [+]
Sensex, Nifty caught in tight band; Sun Pharma gains 4.5% 6.4.2015 Sify Finance
Also found in: [+]
Pharma companies dominate 2014 list of Indian firms filing for global patents 4.4.2015 TOI: India Business
Led by companies such as Ranbaxy, Wockhardt and Hetero, the pharma sector dominates the list of top Indian filers under the Patent Cooperation Treaty (PCT) in 2014, seeking protection internationally for their inventions.
Also found in: [+]
Compulsory licensing hit India’s image: Hetero Pharma 31.3.2015 ET: Pharma
Hyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by not respecting IP norms.
Also found in: [+]
Stada agrees oncology deal with Indian Hetero Drugs 26.3.2015 Sify Finance
FRANKFURT (Reuters) - German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
Also found in: [+]
CAG slams Kerala Ayurveda company for laxity in manufacturing 26.3.2015 ET: Healthcare
The report also said the company admitted that it has the facility to test only microbial and physico-chemical parametres of products.
Also found in: [+]
SC stays HC order restraining firm from manufacturing anti-diabetes drugs 26.3.2015 TOI: India
The Supreme Court on Wednesday stayed a Delhi High Court order restraining Indian pharma company Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the patent rights of US drug major Merck Sharp and Dohme ...
Also found in: [+]
SC stays HC order against Glenmark in patent case 26.3.2015 TOI: India Business
The Supreme Court on Wednesday stayed a Delhi high court order restraining Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the patent rights of US drug major Merck Sharp and Dohme (MSD).
Also found in: [+]
Dilip Shanghvi's success: From a start-up to India's largest drug maker 11.3.2015 Rediff: Business
Dilip Shanghvi founded Sun Pharma in 1983.
Also found in: [+]
Germany's Boehringer loses India patent on lung drug to Cipla 10.3.2015 ET: Pharma
India's patent office ordered the revocation in a decision posted on its website on Thursday.
Also found in: [+]
Germany's Boehringer loses India patent on lung drug to Cipla 10.3.2015 Sify Finance
MUMBAI, March 10 (Reuters) - India has revoked a patent on German pharmaceutical company Boehringer Ingelheim's lung drug Spiriva and ruled in favour of domestic drugmaker Cipla Ltd , in the latest
Also found in: [+]
German firm Boehringer Ingelheim’s patent for asthma drug revoked 10.3.2015 ET: Pharma
India's Patent Office has revoked a patent on asthma drug, Spiriva held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla.
Also found in: [+]
Natco Pharma launches hepatitis C drug in Nepal 10.3.2015 ET: Pharma
The drug launched under the brand name Hepcinat is priced at Rs 19,900, or roughly $300 for 28 tablets, Natco said in its communication to the stock exchanges.
Also found in: [+]
German co’s patent for asthma drug revoked 10.3.2015 TOI: Home
India’s Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla.
Also found in: [+]
Natco Pharma ties up with Gilead on hepatitis C drug 3.3.2015 TOI: India Business
Natco Pharma Ltd., the Indian drugmaker that had challenged Gilead Sciences Inc.'s patent claims on a blockbuster hepatitis C treatment in the Asian country, said it signed a licensing agreement with the US company for the drug.
Also found in: [+]
Natco Pharma ties up with Gilead Sciences for Hepatitis C drug 3.3.2015 ET: Healthcare
Natco was the only Indian generic drug maker that had filed a pre-grant patent opposition for the drug with the patent office.
Also found in: [+]
Obama Versus Obamacare: Acting at Big Pharma’s behest US president hurts India, others and his own legacy 12.2.2015 ET: Pharma
Latest negotiations with India – the leading source of generic drugs for developing countries – are a key part of this strategy.
Also found in: [+]
Big Pharma groupings urges US to ask India to change its IPR policies 12.2.2015 ET: Pharma
IPR issues, especially over drugs, have long been a sticky point in India-US bilateral relations which both countries are now trying to resolve.
Also found in: [+]
1 to 20 of 2,560